HM Pharmaceutical Falls 9.35% on Aug 25 After 30% Surge From $2.3B Roche Deal
According to Yonhapinfomax, HM Pharmaceutical's stock fell 9.35% to 489,500 Korean won on August 25 morning, reversing gains from the previous day when it surged 30% following the announcement of a technology transfer agreement with Roche subsidiary Genentech. The company transferred a non-GLP-1
GateNews·08-25 01:37


